The presence of viruses in the blood.
The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression.
Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.
Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV.
A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
Ribonucleic acid that makes up the genetic material of viruses.
Immunoglobulins produced in response to VIRAL ANTIGENS.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
Deoxyribonucleic acid that makes up the genetic material of viruses.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
Infections with POLYOMAVIRUS, which are often cultured from the urine of kidney transplant patients. Excretion of BK VIRUS is associated with ureteral strictures and CYSTITIS, and that of JC VIRUS with progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL).
Vaccines or candidate vaccines designed to prevent SAIDS; (SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME); and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens.
A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.
Infections with viruses of the family FLAVIVIRIDAE.
An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
A species of virus (unassigned to a genus) in the family FLAVIVIRIDAE. It is genetically heterogeneous, of human origin, and transmitted by blood or blood products. Despite its alternate name (Hepatitis G virus), its pathogenicity remains controversial.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
DNA virus infections refer to diseases caused by viruses that incorporate double-stranded or single-stranded DNA as their genetic material, replicating within host cell nucleus or cytoplasm, and including various families such as Herpesviridae, Adenoviridae, Papillomaviridae, and Parvoviridae.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
A syndrome characterized by outbreaks of late term abortions, high numbers of stillbirths and mummified or weak newborn piglets, and respiratory disease in young unweaned and weaned pigs. It is caused by PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS. (Radostits et al., Veterinary Medicine, 8th ed, p1048)
Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.
A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71)
A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P=O)O2 structure.
INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
Virus diseases caused by the CIRCOVIRIDAE.
Antibodies reactive with HIV ANTIGENS.
A species of ARTERIVIRUS causing reproductive and respiratory disease in pigs. The European strain is called Lelystad virus. Airborne transmission is common.
A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease.
Substances elaborated by viruses that have antigenic activity.
Elements of limited time intervals, contributing to particular results or situations.
A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.
The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.
A species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Agents used to treat RETROVIRIDAE INFECTIONS.
Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
INFLAMMATION of the LIVER in animals due to viral infection.
Virus diseases caused by members of the ALPHAVIRUS genus of the family TOGAVIRIDAE.
Vaccines or candidate vaccines used to prevent infection with WEST NILE VIRUS.
The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION.
Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment.
A genus of the family CIRCOVIRIDAE that infects SWINE; PSITTACINES; and non-psittacine BIRDS. Species include Beak and feather disease virus causing a fatal disease in psittacine birds, and Porcine circovirus causing postweaning multisystemic wasting syndrome in pigs (PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME).
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.
Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis.
A family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.
Vaccines or candidate vaccines used to prevent infection with DENGUE VIRUS. These include live-attenuated, subunit, DNA, and inactivated vaccines.
Vaccine used to prevent YELLOW FEVER. It consists of a live attenuated 17D strain of the YELLOW FEVER VIRUS.
Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules.

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. (1/2101)

BACKGROUND/AIMS: Most patients infected with hepatitis C virus (HCV) develop chronic infection and persistent viraemia. The immune mechanisms responsible for resolution of viraemia remain poorly understood. HCV specific humoral and cellular immune responses in patients with and without viraemia were investigated. METHODS: In vitro T helper (TH) lymphocyte responses to structural and non-structural HCV proteins were determined by means of proliferative response and cytokine production in 35 anti-HCV positive/HCV RNA negative patients and in 31 patients with chronic HCV infection and persistent viraemia. Humoral responses were determined by measuring HCV specific antibody quantity and specificity. RESULTS: A TH response to two or more HCV proteins was present in 18 of 35 patients with serological viral clearance compared with just one of 31 viraemic patients (p = 0.00001). HCV specific interferon-gamma production was increased only in the former group. In contrast, the antibody levels were significantly lower and directed at fewer HCV antigens in patients with undetectable HCV RNA. CONCLUSIONS: Patients without viraemia after HCV infection frequently have strong TH lymphocyte responses of the TH1 type to multiple HCV antigens many years after the onset of infection, whereas antibody responses are less marked. These results suggest that control of HCV replication may depend on effective TH lymphocyte activation.  (+info)

No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users. (2/2101)

The relationship between CCR5 and CCR2b genotypes and human immunodeficiency virus (HIV)-1 disease progression was studied among the 108 seroconverters of the Amsterdam cohort of injecting drug users (IDUs). In contrast to earlier studies among homosexual men, no effect on disease progression of the CCR5 Delta32/+ and the CCR2b 64I/+ genotypes was found, when progression to AIDS, death, or a CD4 cell count <200/microL was compared by a Cox proportional hazards model. Furthermore, CD4 cell decline (by a regression model for repeated measurements) and virus load in the first 3 years after seroconversion did not differ between the CCR5 and CCR2b wild type and heterozygous genotypes. A nested matched case-control study also revealed no significant effect of the CCR5 and CCR2b mutations. Immunologic differences between IDUs and homosexual men may account for the observed lack of effect. Alternatively, difference in transmission route or characteristics of the HIV-1 variants that circulate in IDUs could also explain this phenomenon.  (+info)

Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection. (3/2101)

Chronic active Epstein-Barr virus infection (CAEBV) is a severe illness with unusual EBV activation that persists for years, and its pathogenesis is largely unknown. After the creation of an accurate and reproducible polymerase chain reaction system to quantify EBV DNA, virus loads in peripheral blood lymphocytes (PBL) were determined in 54 children: 15 with CAEBV, 16 with infectious mononucleosis (IM), and 23 healthy children. Children with CAEBV and those with IM had high virus loads. Lower loads were detected in 47% of seropositive healthy donors. There were two distinct differences between children with CAEBV and those with IM: The former had greater viral replication (10(3)-10(7) copies/2.5x10(5) PBL) than those with IM, and viral replication declined in children with IM whereas active replication persisted for years in subjects with CAEBV. Persisting high virus loads are a possible diagnostic criterion for CAEBV. EBV loads may enable classification and prognosis of EBV infections.  (+info)

High prevalence of hepatitis G virus (HGV) infections in dialysis staff. (4/2101)

BACKGROUND: Patients on renal replacement therapy, haemodialysis (HD), or after kidney transplantation (TX), are known to be at risk of acquiring blood-borne infections (HBV, HCV). GBV-C/Hepatitis G virus (HGV) has been described recently and is considered to cause blood-borne infections. The aim of this study was to analyse the risk for the medical staff of HD and TX patients to acquire HGV infection. METHODS: Eighty-five HD patients and 86 TX recipients were compared with 49 health-care workers and 64 blood donors as controls. The HGV prevalence was determined by RT-PCR and antibodies to E2 protein. RESULTS: A high prevalence of HGV was found in the medical staff (24%) which nearly corresponded to the prevalence of the patients (TX 36%, HD 25%) but not to the controls (9%). In contrast, the prevalence of HCV was low in the medical staff (2%) and controls (0%) but high in HD (13%) and TX (13%). Age and duration of employment in the department did not significantly influence the HGV prevalence in staff. The number of viraemic subjects in staff was high, possibly indicating a more recent infection. CONCLUSION: An occupational risk for HGV exists in medical staff of dialysis and transplant patients. Further routes of transmission than only parenteral may play a role in this setting.  (+info)

Activation in vivo of retroperitoneal fibromatosis-associated herpesvirus, a simian homologue of human herpesvirus-8. (5/2101)

Retroperitoneal fibromatosis-associated herpesvirus of rhesus macaques (RFHVMm) is a gammaherpesvirus closely related to human herpesvirus-8 (HHV-8), which is thought to be a necessary cofactor for the development of Kaposi's sarcoma (KS) in humans. Here, RFHVMm infection of rhesus macaques exposed to the D-type retrovirus simian retrovirus-2 (SRV-2) is described. Development of SRV-2 viraemia, infection with simian immunodeficiency virus or administration of cyclosporin A could result in persistent RFHVMm viraemia. From this, it is concluded that productive retrovirus infection or otherwise-induced immune suppression has the ability to activate this herpesvirus in vivo. Elevated levels of circulating interleukin-6, a cytokine that plays a central role in KS, were found in RFHVMm-viraemic animals. In viraemic animals, RFHVMm was found in tissues that are common sites for the development of AIDS-associated KS, especially the oral cavity. Together, these data suggest a common biology between RFHVMm infection of macaques and HHV-8 infection and pathogenesis in humans.  (+info)

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. (6/2101)

Human cytomegalovirus (HCMV) infection was monitored retrospectively by qualitative determination of pp67 mRNA (a late viral transcript) by nucleic acid sequence-based amplification (NASBA) in a series of 50 transplant recipients, including 26 solid-organ (11 heart and 15 lung) transplant recipients (SOTRs) and 24 bone marrow transplant recipients (BMTRs). NASBA results were compared with those obtained by prospective quantitation of HCMV viremia and antigenemia and retrospective quantitation of DNA in leukocytes (leukoDNAemia). On the whole, 29 patients were NASBA positive, whereas 10 were NASBA negative, and the blood of 11 patients remained HCMV negative. NASBA detected HCMV infection before quantitation of viremia did but after quantitation of leukoDNAemia and antigenemia did. In NASBA-positive blood samples, median levels of viremia, antigenemia, and leukoDNAemia were significantly higher than the relevant levels detected in NASBA-negative HCMV-positive blood samples. By using the quantitation of leukoDNAemia as the "gold standard," the analytical sensitivity (47.3%), as well as the negative predictive value (68. 3%), of NASBA for the diagnosis of HCMV infection intermediate between that of antigenemia quantitation (analytical sensitivity, 72. 3%) and that of viremia quantitation (analytical sensitivity, 28.7%), while the specificity and the positive predictive value were high (90 to 100%). However, with respect to the clinically relevant antigenemia cutoff of >/=100 used in this study for the initiation of preemptive therapy in SOTRs with reactivated HCMV infection, the clinical sensitivity of NASBA reached 100%, with a specificity of 68. 9%. Upon the initiation of antigenemia quantitation-guided treatment, the actual median antigenemia level was 158 (range, 124 to 580) in SOTRs who had reactivated infection and who presented with NASBA positivity 3.5 +/- 2.6 days in advance and 13.5 (range, 1 to 270) in the group that included BMTRs and SOTRs who had primary infection (in whom treatment was initiated upon the first confirmation of detection of HCMV in blood) and who presented with NASBA positivity 2.0 +/- 5.1 days later. Following antiviral treatment, the durations of the presence of antigenemia and pp67 mRNA in blood were found to be similar. In conclusion, monitoring of the expression of HCMV pp67 mRNA appears to be a promising, well-standardized tool for determination of the need for the initiation and termination of preemptive therapy. Its overall clinical impact should be analyzed in future prospective studies.  (+info)

Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. (7/2101)

We compared the Digene Hybrid Capture CMV DNA Assay version 2.0, the pp65 antigenemia assay, traditional tube culture, and shell vial culture for the detection of cytomegalovirus (CMV) viremia in several patient populations at three centers. Of 561 blood specimens collected from 402 patients, complete clinical and laboratory data were available for 489. Using consensus definitions for true positives and true negatives, the sensitivities of the Hybrid Capture assay, antigenemia, shell vial, and tube culture were 95, 94, 43, and 46%, respectively. The specificities of the Hybrid Capture assay and antigenemia were 95 and 94%, respectively. At all three study sites, the detected level of CMV viremia was significantly higher with the Hybrid Capture assay or antigenemia than with shell vial and tube culture. In a group of 131 healthy nonimmunosuppressed volunteers, the Hybrid Capture assay demonstrated a specificity of over 99%. The Hybrid Capture assay is a standardized assay that is simple to perform and can utilize whole blood specimens that have been stored for up to 48 h. The high sensitivity and specificity of the Hybrid Capture assay along with its simplicity and flexibility make it a clinically useful assay for the detection of CMV viremia in immunocompromised or immunosuppressed patients. Further evaluation to determine its role in predicting CMV disease and for monitoring the therapeutic response to anti-CMV therapy is needed.  (+info)

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. (8/2101)

To determine the role of CD8(+) T cells in controlling simian immunodeficiency virus (SIV) replication in vivo, we examined the effect of depleting this cell population using an anti-CD8 monoclonal antibody, OKT8F. There was on average a 99.9% reduction of CD8 cells in peripheral blood in six infected Macaca mulatta treated with OKT8F. The apparent CD8 depletion started 1 h after antibody administration, and low CD8 levels were maintained until day 8. An increase in plasma viremia of one to three orders of magnitude was observed in five of the six macaques. The injection of a control antibody to an infected macaque did not induce a sustained viral load increase, nor did it significantly reduce the number of CD8(+) T cells. These results demonstrate that CD8 cells play a crucial role in suppressing SIV replication in vivo.  (+info)

Viremia is a medical term that refers to the presence of viruses in the bloodstream. It occurs when a virus successfully infects a host and replicates within the body's cells, releasing new viral particles into the blood. This condition can lead to various clinical manifestations depending on the specific virus involved and the immune response of the infected individual. Some viral infections result in asymptomatic viremia, while others can cause severe illness or even life-threatening conditions. The detection of viremia is crucial for diagnosing certain viral infections and monitoring disease progression or treatment effectiveness.

Viral load refers to the amount or quantity of virus (like HIV, Hepatitis C, SARS-CoV-2) present in an individual's blood or bodily fluids. It is often expressed as the number of virus copies per milliliter of blood or fluid. Monitoring viral load is important in managing and treating certain viral infections, as a higher viral load may indicate increased infectivity, disease progression, or response to treatment.

Simian Acquired Immunodeficiency Syndrome (SAIDS) is not recognized as a medical condition in humans. However, it is a disease that affects non-human primates like African green monkeys and sooty mangabeys. SAIDS is caused by the Simian Immunodeficiency Virus (SIV), which is similar to the Human Immunodeficiency Virus (HIV) that leads to Acquired Immunodeficiency Syndrome (AIDS) in humans.

In non-human primates, SIV infection can lead to a severe immunodeficiency state, characterized by the destruction of CD4+ T cells and impaired immune function, making the host susceptible to various opportunistic infections and cancers. However, it is important to note that most non-human primates infected with SIV do not develop SAIDS spontaneously, unlike humans who acquire HIV infection.

In summary, Simian Acquired Immunodeficiency Syndrome (SAIDS) is a disease affecting non-human primates due to Simian Immunodeficiency Virus (SIV) infection, characterized by immunodeficiency and susceptibility to opportunistic infections and cancers. It should not be confused with Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome (HIV/AIDS) in humans.

Simian Immunodeficiency Virus (SIV) is a retrovirus that primarily infects African non-human primates and is the direct ancestor of Human Immunodeficiency Virus type 2 (HIV-2). It is similar to HIV in its structure, replication strategy, and ability to cause an immunodeficiency disease in its host. SIV infection in its natural hosts is typically asymptomatic and non-lethal, but it can cause AIDS-like symptoms in other primate species. Research on SIV in its natural hosts has provided valuable insights into the mechanisms of HIV pathogenesis and potential strategies for prevention and treatment of AIDS.

"Macaca mulatta" is the scientific name for the Rhesus macaque, a species of monkey that is native to South, Central, and Southeast Asia. They are often used in biomedical research due to their genetic similarity to humans.

HIV (Human Immunodeficiency Virus) infection is a viral illness that progressively attacks and weakens the immune system, making individuals more susceptible to other infections and diseases. The virus primarily infects CD4+ T cells, a type of white blood cell essential for fighting off infections. Over time, as the number of these immune cells declines, the body becomes increasingly vulnerable to opportunistic infections and cancers.

HIV infection has three stages:

1. Acute HIV infection: This is the initial stage that occurs within 2-4 weeks after exposure to the virus. During this period, individuals may experience flu-like symptoms such as fever, fatigue, rash, swollen glands, and muscle aches. The virus replicates rapidly, and the viral load in the body is very high.
2. Chronic HIV infection (Clinical latency): This stage follows the acute infection and can last several years if left untreated. Although individuals may not show any symptoms during this phase, the virus continues to replicate at low levels, and the immune system gradually weakens. The viral load remains relatively stable, but the number of CD4+ T cells declines over time.
3. AIDS (Acquired Immunodeficiency Syndrome): This is the most advanced stage of HIV infection, characterized by a severely damaged immune system and numerous opportunistic infections or cancers. At this stage, the CD4+ T cell count drops below 200 cells/mm3 of blood.

It's important to note that with proper antiretroviral therapy (ART), individuals with HIV infection can effectively manage the virus, maintain a healthy immune system, and significantly reduce the risk of transmission to others. Early diagnosis and treatment are crucial for improving long-term health outcomes and reducing the spread of HIV.

HIV-1 (Human Immunodeficiency Virus type 1) is a species of the retrovirus genus that causes acquired immunodeficiency syndrome (AIDS). It is primarily transmitted through sexual contact, exposure to infected blood or blood products, and from mother to child during pregnancy, childbirth, or breastfeeding. HIV-1 infects vital cells in the human immune system, such as CD4+ T cells, macrophages, and dendritic cells, leading to a decline in their numbers and weakening of the immune response over time. This results in the individual becoming susceptible to various opportunistic infections and cancers that ultimately cause death if left untreated. HIV-1 is the most prevalent form of HIV worldwide and has been identified as the causative agent of the global AIDS pandemic.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

Cytomegalovirus (CMV) infections are caused by the human herpesvirus 5 (HHV-5), a type of herpesvirus. The infection can affect people of all ages, but it is more common in individuals with weakened immune systems, such as those with HIV/AIDS or who have undergone organ transplantation.

CMV can be spread through close contact with an infected person's saliva, urine, blood, tears, semen, or breast milk. It can also be spread through sexual contact or by sharing contaminated objects, such as toys, eating utensils, or drinking glasses. Once a person is infected with CMV, the virus remains in their body for life and can reactivate later, causing symptoms to recur.

Most people who are infected with CMV do not experience any symptoms, but some may develop a mononucleosis-like illness, characterized by fever, fatigue, swollen glands, and sore throat. In people with weakened immune systems, CMV infections can cause more severe symptoms, including pneumonia, gastrointestinal disease, retinitis, and encephalitis.

Congenital CMV infection occurs when a pregnant woman passes the virus to her fetus through the placenta. This can lead to serious complications, such as hearing loss, vision loss, developmental delays, and mental disability.

Diagnosis of CMV infections is typically made through blood tests or by detecting the virus in bodily fluids, such as urine or saliva. Treatment depends on the severity of the infection and the patient's overall health. Antiviral medications may be prescribed to help manage symptoms and prevent complications.

BK virus, also known as BK polyomavirus, is a type of virus that belongs to the Polyomaviridae family. It is named after the initials of a patient in whom the virus was first isolated. The BK virus is a common infection in humans and is typically acquired during childhood. After the initial infection, the virus remains dormant in the body, often found in the urinary tract and kidneys.

In immunocompetent individuals, the virus usually does not cause any significant problems. However, in people with weakened immune systems, such as those who have undergone organ transplantation or have HIV/AIDS, BK virus can lead to severe complications. One of the most common manifestations of BK virus infection in immunocompromised individuals is hemorrhagic cystitis, a condition characterized by inflammation and bleeding in the bladder. In transplant recipients, BK virus can also cause nephropathy, leading to kidney damage or even failure.

There is no specific treatment for BK virus infection, but antiviral medications may be used to help control the virus's replication in some cases. Maintaining a strong immune system and monitoring viral load through regular testing are essential strategies for managing BK virus infections in immunocompromised individuals.

A CD4 lymphocyte count is a laboratory test that measures the number of CD4 T-cells (also known as CD4+ T-cells or helper T-cells) in a sample of blood. CD4 cells are a type of white blood cell that plays a crucial role in the body's immune response, particularly in fighting off infections caused by viruses and other pathogens.

CD4 cells express a protein on their surface called the CD4 receptor, which is used by human immunodeficiency virus (HIV) to infect and destroy these cells. As a result, people with HIV infection or AIDS often have low CD4 lymphocyte counts, which can make them more susceptible to opportunistic infections and other complications.

A normal CD4 lymphocyte count ranges from 500 to 1,200 cells per cubic millimeter of blood (cells/mm3) in healthy adults. A lower than normal CD4 count is often used as a marker for the progression of HIV infection and the development of AIDS. CD4 counts are typically monitored over time to assess the effectiveness of antiretroviral therapy (ART) and to guide clinical decision-making regarding the need for additional interventions, such as prophylaxis against opportunistic infections.

Antiretroviral Therapy, Highly Active (HAART) is a medical treatment regimen used to manage HIV infection. It involves the combination of three or more antiretroviral drugs from at least two different classes, aiming to maximally suppress viral replication and prevent the development of drug resistance. The goal of HAART is to reduce the amount of HIV in the body to undetectable levels, preserve immune function, and improve quality of life for people living with HIV. Commonly used antiretroviral classes include nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and fusion inhibitors.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

Anti-HIV agents are a class of medications specifically designed to treat HIV (Human Immunodeficiency Virus) infection. These drugs work by interfering with various stages of the HIV replication cycle, preventing the virus from infecting and killing CD4+ T cells, which are crucial for maintaining a healthy immune system.

There are several classes of anti-HIV agents, including:

1. Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs): These drugs act as faulty building blocks that the virus incorporates into its genetic material, causing the replication process to halt. Examples include zidovudine (AZT), lamivudine (3TC), and tenofovir.
2. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs): These medications bind directly to the reverse transcriptase enzyme, altering its shape and preventing it from functioning properly. Examples include efavirenz, nevirapine, and rilpivirine.
3. Protease Inhibitors (PIs): These drugs target the protease enzyme, which is responsible for cleaving viral polyproteins into functional components. By inhibiting this enzyme, PIs prevent the formation of mature, infectious virus particles. Examples include atazanavir, darunavir, and lopinavir.
4. Integrase Strand Transfer Inhibitors (INSTIs): These medications block the integrase enzyme, which is responsible for inserting the viral genetic material into the host cell's DNA. By inhibiting this step, INSTIs prevent the virus from establishing a permanent infection within the host cell. Examples include raltegravir, dolutegravir, and bictegravir.
5. Fusion/Entry Inhibitors: These drugs target different steps of the viral entry process, preventing HIV from infecting CD4+ T cells. Examples include enfuvirtide (T-20), maraviroc, and ibalizumab.
6. Post-Attachment Inhibitors: This class of medications prevents the virus from attaching to the host cell's receptors, thereby inhibiting infection. Currently, there is only one approved post-attachment inhibitor, fostemsavir.

Combination therapy using multiple classes of antiretroviral drugs has been shown to effectively suppress viral replication and improve clinical outcomes in people living with HIV. Regular adherence to the prescribed treatment regimen is crucial for maintaining an undetectable viral load and reducing the risk of transmission.

CD4-positive T-lymphocytes, also known as CD4+ T cells or helper T cells, are a type of white blood cell that plays a crucial role in the immune response. They express the CD4 receptor on their surface and help coordinate the immune system's response to infectious agents such as viruses and bacteria.

CD4+ T cells recognize and bind to specific antigens presented by antigen-presenting cells, such as dendritic cells or macrophages. Once activated, they can differentiate into various subsets of effector cells, including Th1, Th2, Th17, and Treg cells, each with distinct functions in the immune response.

CD4+ T cells are particularly important in the immune response to HIV (human immunodeficiency virus), which targets and destroys these cells, leading to a weakened immune system and increased susceptibility to opportunistic infections. The number of CD4+ T cells is often used as a marker of disease progression in HIV infection, with lower counts indicating more advanced disease.

A viral vaccine is a biological preparation that introduces your body to a specific virus in a way that helps your immune system build up protection against the virus without causing the illness. Viral vaccines can be made from weakened or inactivated forms of the virus, or parts of the virus such as proteins or sugars. Once introduced to the body, the immune system recognizes the virus as foreign and produces an immune response, including the production of antibodies. These antibodies remain in the body and provide immunity against future infection with that specific virus.

Viral vaccines are important tools for preventing infectious diseases caused by viruses, such as influenza, measles, mumps, rubella, polio, hepatitis A and B, rabies, rotavirus, chickenpox, shingles, and some types of cancer. Vaccination programs have led to the control or elimination of many infectious diseases that were once common.

It's important to note that viral vaccines are not effective against bacterial infections, and separate vaccines must be developed for each type of virus. Additionally, because viruses can mutate over time, it is necessary to update some viral vaccines periodically to ensure continued protection.

Polyomavirus infections refer to the infectious diseases caused by polyomaviruses, a type of small, non-enveloped DNA viruses that are capable of infecting humans and animals. There are several different types of polyomaviruses that can cause infection, including JC virus (JCV), BK virus (BKV), KI virus (KIV), WU virus (WUV), and Merkel cell polyomavirus (MCPyV).

Infection with these viruses typically occurs during childhood and is usually asymptomatic or associated with mild respiratory illness. However, in immunocompromised individuals, such as those with HIV/AIDS or organ transplant recipients, polyomavirus infections can lead to more serious complications, including nephropathy (BKV), progressive multifocal leukoencephalopathy (JCV), and Merkel cell carcinoma (MCPyV).

Diagnosis of polyomavirus infections typically involves the detection of viral DNA or antigens in clinical samples, such as blood, urine, or tissue biopsies. Treatment is generally supportive and aimed at managing symptoms, although antiviral therapy may be used in some cases. Prevention strategies include good hygiene practices and avoiding close contact with individuals who are known to be infected.

I believe there may be a slight confusion in your question. AIDS is a condition caused by the human immunodeficiency virus (HIV) infection, and it weakens the immune system, making people more susceptible to other infections and diseases. There is no vaccine for AIDS itself. However, there are vaccines being developed and tested to prevent HIV infection, which would help prevent AIDS from developing.

SAIDS is not a medical term. If you meant to ask about "HIV vaccines," I can provide a definition:

An HIV vaccine aims to stimulate the immune system to produce an effective response against the human immunodeficiency virus (HIV). An effective HIV vaccine would ideally prevent the initial infection or significantly reduce viral replication and disease progression in infected individuals. Currently, no licensed HIV vaccines are available, but research is ongoing to develop a protective vaccine against HIV infection.

Dengue virus (DENV) is a single-stranded, positive-sense RNA virus that belongs to the genus Flavivirus in the family Flaviviridae. It is primarily transmitted to humans through the bites of infected female mosquitoes, mainly Aedes aegypti and Aedes albopictus.

The DENV genome contains approximately 11,000 nucleotides and encodes three structural proteins (capsid, pre-membrane/membrane, and envelope) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). There are four distinct serotypes of DENV (DENV-1, DENV-2, DENV-3, and DENV-4), each of which can cause dengue fever, a mosquito-borne viral disease.

Infection with one serotype provides lifelong immunity against that particular serotype but only temporary and partial protection against the other three serotypes. Subsequent infections with different serotypes can increase the risk of developing severe dengue, such as dengue hemorrhagic fever or dengue shock syndrome, due to antibody-dependent enhancement (ADE) and original antigenic sin phenomena.

DENV is a significant public health concern in tropical and subtropical regions worldwide, with an estimated 390 million annual infections and approximately 100-400 million clinical cases. Preventive measures include vector control strategies to reduce mosquito populations and the development of effective vaccines against all four serotypes.

Flaviviridae infections refer to a group of diseases caused by viruses that belong to the Flaviviridae family. This family includes several important human pathogens, such as dengue virus, yellow fever virus, West Nile virus, Japanese encephalitis virus, and Zika virus.

These viruses are primarily transmitted to humans through the bites of infected mosquitoes or ticks. The symptoms of Flaviviridae infections can vary depending on the specific virus, but they often include fever, headache, muscle and joint pain, rash, and fatigue. In severe cases, these infections can lead to serious complications such as hemorrhagic fever, encephalitis, or neuropathy.

Prevention measures for Flaviviridae infections include avoiding mosquito and tick bites, using insect repellent, wearing protective clothing, and getting vaccinated if vaccines are available for the specific virus. Treatment is generally supportive and may include fluid replacement, pain relief, and management of complications. There are no specific antiviral treatments available for most Flaviviridae infections.

Dengue is a mosquito-borne viral infection that is primarily transmitted by the Aedes aegypti and Aedes albopictus species of mosquitoes. It is caused by one of four closely related dengue viruses (DENV 1, DENV 2, DENV 3, or DENV 4). The infection can cause a wide range of symptoms, ranging from mild fever and headache to severe flu-like illness, which is often characterized by the sudden onset of high fever, severe headache, muscle and joint pain, nausea, vomiting, and skin rash. In some cases, dengue can progress to more severe forms, such as dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening if not treated promptly and appropriately.

Dengue is prevalent in many tropical and subtropical regions around the world, particularly in urban and semi-urban areas with poor sanitation and inadequate mosquito control. There is no specific treatment for dengue, and prevention efforts focus on reducing mosquito populations and avoiding mosquito bites. Vaccines are available in some countries to prevent dengue infection, but they are not widely used due to limitations in their effectiveness and safety.

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It's primarily spread through contact with contaminated blood, often through sharing needles or other equipment to inject drugs. For some people, hepatitis C is a short-term illness but for most — about 75-85% — it becomes a long-term, chronic infection that can lead to serious health problems like liver damage, liver failure, and even liver cancer. The virus can infect and inflame the liver, causing symptoms like jaundice (yellowing of the skin and eyes), abdominal pain, fatigue, and dark urine. Many people with hepatitis C don't have any symptoms, so they might not know they have the infection until they experience complications. There are effective treatments available for hepatitis C, including antiviral medications that can cure the infection in most people. Regular testing is important to diagnose and treat hepatitis C early, before it causes serious health problems.

GB virus C (GBV-C), also known as hepatitis G virus (HGV) or human pegivirus (HPgV), is a single-stranded, positive-sense RNA virus that belongs to the Flaviviridae family. It was initially identified in 1995 and is closely related to hepatitis C virus (HCV). However, unlike HCV, GBV-C is not associated with any significant liver disease and does not cause hepatitis.

GBV-C infection is usually asymptomatic and often resolves on its own without treatment. It is primarily transmitted through blood and bodily fluids, such as through sharing needles or during sexual contact. Vertical transmission from mother to child can also occur, although it is less common than with HCV.

While GBV-C infection is generally benign, there is some evidence to suggest that it may have immunomodulatory effects and could potentially impact the course of other viral infections, such as HIV. However, more research is needed to fully understand the clinical significance of GBV-C infection.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Cytomegalovirus (CMV) is a type of herpesvirus that can cause infection in humans. It is characterized by the enlargement of infected cells (cytomegaly) and is typically transmitted through close contact with an infected person, such as through saliva, urine, breast milk, or sexual contact.

CMV infection can also be acquired through organ transplantation, blood transfusions, or during pregnancy from mother to fetus. While many people infected with CMV experience no symptoms, it can cause serious complications in individuals with weakened immune systems, such as those undergoing cancer treatment or those who have HIV/AIDS.

In newborns, congenital CMV infection can lead to hearing loss, vision problems, and developmental delays. Pregnant women who become infected with CMV for the first time during pregnancy are at higher risk of transmitting the virus to their unborn child. There is no cure for CMV, but antiviral medications can help manage symptoms and reduce the risk of complications in severe cases.

CD8-positive T-lymphocytes, also known as CD8+ T cells or cytotoxic T cells, are a type of white blood cell that plays a crucial role in the adaptive immune system. They are named after the CD8 molecule found on their surface, which is a protein involved in cell signaling and recognition.

CD8+ T cells are primarily responsible for identifying and destroying virus-infected cells or cancerous cells. When activated, they release cytotoxic granules that contain enzymes capable of inducing apoptosis (programmed cell death) in the target cells. They also produce cytokines such as interferon-gamma, which can help coordinate the immune response and activate other immune cells.

CD8+ T cells are generated in the thymus gland and are a type of T cell, which is a lymphocyte that matures in the thymus and plays a central role in cell-mediated immunity. They recognize and respond to specific antigens presented on the surface of infected or cancerous cells in conjunction with major histocompatibility complex (MHC) class I molecules.

Overall, CD8+ T cells are an essential component of the immune system's defense against viral infections and cancer.

HIV (Human Immunodeficiency Virus) is a species of lentivirus (a subgroup of retrovirus) that causes HIV infection and over time, HIV infection can lead to AIDS (Acquired Immunodeficiency Syndrome). This virus attacks the immune system, specifically the CD4 cells, also known as T cells, which are a type of white blood cell that helps coordinate the body's immune response. As HIV destroys these cells, the body becomes more vulnerable to other infections and diseases. It is primarily spread through bodily fluids like blood, semen, vaginal fluids, and breast milk.

It's important to note that while there is no cure for HIV, with proper medical care, HIV can be controlled. Treatment for HIV is called antiretroviral therapy (ART). If taken as prescribed, this medicine reduces the amount of HIV in the body to a very low level, which keeps the immune system working and prevents illness. This treatment also greatly reduces the risk of transmission.

Virus shedding refers to the release of virus particles by an infected individual, who can then transmit the virus to others through various means such as respiratory droplets, fecal matter, or bodily fluids. This occurs when the virus replicates inside the host's cells and is released into the surrounding environment, where it can infect other individuals. The duration of virus shedding varies depending on the specific virus and the individual's immune response. It's important to note that some individuals may shed viruses even before they show symptoms, making infection control measures such as hand hygiene, mask-wearing, and social distancing crucial in preventing the spread of infectious diseases.

DNA virus infections refer to diseases or conditions caused by the invasion and replication of DNA viruses in a host organism. DNA viruses are a type of virus that uses DNA as their genetic material. They can cause a variety of diseases, ranging from relatively mild illnesses to severe or life-threatening conditions.

Some examples of DNA viruses include herpes simplex virus (HSV), varicella-zoster virus (VZV), human papillomavirus (HPV), hepatitis B virus (HBV), and adenoviruses. These viruses can cause a range of diseases, including cold sores, genital herpes, chickenpox, shingles, cervical cancer, liver cancer, and respiratory infections.

DNA virus infections typically occur when the virus enters the body through a break in the skin or mucous membranes, such as those found in the eyes, nose, mouth, or genitals. Once inside the body, the virus infects cells and uses their machinery to replicate itself, often causing damage to the host cells in the process.

The symptoms of DNA virus infections can vary widely depending on the specific virus and the severity of the infection. Treatment may include antiviral medications, which can help to reduce the severity and duration of symptoms, as well as prevent the spread of the virus to others. In some cases, vaccines may be available to prevent DNA virus infections.

Neutralization tests are a type of laboratory assay used in microbiology and immunology to measure the ability of a substance, such as an antibody or antitoxin, to neutralize the activity of a toxin or infectious agent. In these tests, the substance to be tested is mixed with a known quantity of the toxin or infectious agent, and the mixture is then incubated under controlled conditions. After incubation, the mixture is tested for residual toxicity or infectivity using a variety of methods, such as cell culture assays, animal models, or biochemical assays.

The neutralization titer is then calculated based on the highest dilution of the test substance that completely neutralizes the toxin or infectious agent. Neutralization tests are commonly used in the diagnosis and evaluation of immune responses to vaccines, as well as in the detection and quantification of toxins and other harmful substances.

Examples of neutralization tests include the serum neutralization test for measles antibodies, the plaque reduction neutralization test (PRNT) for dengue virus antibodies, and the cytotoxicity neutralization assay for botulinum neurotoxins.

Hepacivirus is a genus of viruses in the family Flaviviridae. The most well-known member of this genus is Hepatitis C virus (HCV), which is a major cause of liver disease worldwide. HCV infection can lead to chronic hepatitis, cirrhosis, and liver cancer.

Hepaciviruses are enveloped viruses with a single-stranded, positive-sense RNA genome. They have a small icosahedral capsid and infect a variety of hosts, including humans, non-human primates, horses, and birds. The virus enters the host cell by binding to specific receptors on the cell surface and is then internalized through endocytosis.

HCV has a high degree of genetic diversity and is classified into seven major genotypes and numerous subtypes based on differences in its RNA sequence. This genetic variability can affect the virus's ability to evade the host immune response, making treatment more challenging.

In addition to HCV, other hepaciviruses have been identified in various animal species, including equine hepacivirus (EHCV), rodent hepacivirus (RHV), and bat hepacivirus (BtHepCV). These viruses are being studied to better understand the biology of hepaciviruses and their potential impact on human health.

Porcine Reproductive and Respiratory Syndrome (PRRS) is a viral disease that affects pigs, causing reproductive failure in breeding herds and respiratory illness in young pigs. The disease is caused by the PRRS virus, which belongs to the family Arteriviridae.

In pregnant sows, PRRS can cause abortions, stillbirths, mummified fetuses, and weak or infertile offspring. In growing pigs, it can lead to pneumonia, reduced growth rates, and increased susceptibility to other infections. The virus is highly contagious and can spread rapidly within a herd through direct contact with infected pigs, aerosols, or contaminated fomites.

PRRS is a significant disease of global importance, causing substantial economic losses to the swine industry. Control measures include biosecurity practices, vaccination, and testing to detect and eliminate the virus from affected herds. However, there is no specific treatment for PRRS, and eradication of the virus from the pig population is unlikely due to its widespread distribution and ability to persist in infected animals and the environment.

Neutralizing antibodies are a type of antibody that defends against pathogens such as viruses or bacteria by neutralizing their ability to infect cells. They do this by binding to specific regions on the surface proteins of the pathogen, preventing it from attaching to and entering host cells. This renders the pathogen ineffective and helps to prevent or reduce the severity of infection. Neutralizing antibodies can be produced naturally in response to an infection or vaccination, or they can be generated artificially for therapeutic purposes.

West Nile Fever is defined as a viral infection primarily transmitted to humans through the bite of infected mosquitoes. The virus responsible for this febrile illness, known as West Nile Virus (WNV), is maintained in nature between mosquito vectors and avian hosts. Although most individuals infected with WNV are asymptomatic, some may develop a mild, flu-like illness characterized by fever, headache, fatigue, body aches, skin rash, and swollen lymph glands. A minority of infected individuals, particularly the elderly and immunocompromised, may progress to severe neurological symptoms such as encephalitis (inflammation of the brain), meningitis (inflammation of the membranes surrounding the brain and spinal cord), or acute flaccid paralysis (sudden weakness in the limbs). The diagnosis is confirmed through laboratory tests, such as serological assays or nucleic acid amplification techniques. Treatment primarily focuses on supportive care, as there are no specific antiviral therapies available for West Nile Fever. Preventive measures include personal protection against mosquito bites and vector control strategies to reduce mosquito populations.

West Nile Virus (WNV) is an Flavivirus, which is a type of virus that is spread by mosquitoes. It was first discovered in the West Nile district of Uganda in 1937 and has since been found in many countries throughout the world. WNV can cause a mild to severe illness known as West Nile fever.

Most people who become infected with WNV do not develop any symptoms, but some may experience fever, headache, body aches, joint pain, vomiting, diarrhea, or a rash. In rare cases, the virus can cause serious neurological illnesses such as encephalitis (inflammation of the brain) or meningitis (inflammation of the membranes surrounding the brain and spinal cord). These severe forms of the disease can be fatal, especially in older adults and people with weakened immune systems.

WNV is primarily transmitted to humans through the bite of infected mosquitoes, but it can also be spread through blood transfusions, organ transplants, or from mother to baby during pregnancy, delivery, or breastfeeding. There is no specific treatment for WNV, and most people recover on their own with rest and supportive care. However, hospitalization may be necessary in severe cases. Prevention measures include avoiding mosquito bites by using insect repellent, wearing long sleeves and pants, and staying indoors during peak mosquito activity hours.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Organophosphonates are a class of organic compounds characterized by the presence of a carbon-phosphorus bond. They contain a phosphonic acid group, which consists of a phosphorus atom bonded to four oxygen or nitrogen atoms, with one of those bonds being replaced by a carbon atom.

In a medical context, organophosphonates are commonly used as radiopharmaceuticals in diagnostic nuclear medicine procedures, such as bone scans. These compounds have the ability to bind to hydroxyapatite, the mineral component of bones, and can be labeled with radioactive isotopes for imaging purposes. They may also be used in therapeutic settings, including as treatments for conditions such as tumor-induced hypercalcemia and Paget's disease of bone.

It is important to note that organophosphonates are distinct from organophosphates, another class of compounds that contain a phosphorus atom bonded to three oxygen or sulfur atoms and one carbon atom. Organophosphates have been widely used as pesticides and chemical warfare agents, and can pose significant health risks due to their toxicity.

Viral hepatitis in humans refers to inflammation of the liver caused by infection with viruses that primarily target the liver. There are five main types of human viral hepatitis, designated as Hepatitis A, B, C, D, and E virus (HAV, HBV, HCV, HDV, and HEV). These viruses can cause a range of illnesses, from acute self-limiting hepatitis to chronic hepatitis, which can lead to cirrhosis and liver cancer.

1. Hepatitis A virus (HAV) is typically spread through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection, but rarely can cause chronic hepatitis in individuals with weakened immune systems.
2. Hepatitis B virus (HBV) is primarily transmitted through contact with infected blood, semen, and other bodily fluids. It can lead to both acute and chronic hepatitis, which may result in cirrhosis and liver cancer if left untreated.
3. Hepatitis C virus (HCV) is predominantly spread through exposure to infected blood, such as through sharing needles or receiving contaminated blood transfusions. Chronic hepatitis C is common, and it can lead to serious liver complications like cirrhosis and liver cancer if not treated.
4. Hepatitis D virus (HDV) is an incomplete virus that requires the presence of HBV for its replication. HDV infection occurs only in individuals already infected with HBV, leading to more severe liver disease compared to HBV monoinfection.
5. Hepatitis E virus (HEV) is primarily transmitted through the fecal-oral route, often through contaminated food or water. It usually results in an acute self-limiting infection but can cause chronic hepatitis in pregnant women and individuals with weakened immune systems.

Prevention measures include vaccination for HAV and HBV, safe sex practices, avoiding sharing needles, and ensuring proper hygiene and sanitation to prevent fecal-oral transmission.

An AIDS vaccine is a type of preventive vaccine that aims to stimulate the immune system to produce an effective response against the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS). The goal of an AIDS vaccine is to induce the production of immune cells and proteins that can recognize and eliminate HIV-infected cells, thereby preventing the establishment of a persistent infection.

Despite decades of research, there is still no licensed AIDS vaccine available. This is due in part to the unique challenges posed by HIV, which has a high mutation rate and can rapidly evolve to evade the immune system's defenses. However, several promising vaccine candidates are currently being tested in clinical trials around the world, and researchers continue to explore new approaches and strategies for developing an effective AIDS vaccine.

Circoviridae is a family of small, non-enveloped viruses that infect a wide range of hosts, including animals and birds. The infection caused by circoviruses in animals and birds can result in a variety of symptoms depending on the species infected and the particular circovirus involved.

In pigs, circovirus type 2 (PCV2) is the most well-known member of this family and is associated with a number of clinical conditions, collectively known as porcine circovirus diseases (PCVD). These conditions include postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and reproductive failure.

In birds, circoviruses can cause various symptoms such as runting and stunting, feather abnormalities, and immunosuppression, leading to secondary infections. The most well-known avian circovirus is the beak and feather disease virus (BFDV), which infects psittacine birds, including parrots, causing beak deformities, feather loss, and immune suppression.

However, it's important to note that circoviruses are also found in humans, but currently, there is no evidence that human circovirus infections cause disease.

In general, circoviridae infections can be diagnosed through various laboratory tests such as PCR, sequencing, and serology. Treatment typically involves supportive care and management of secondary infections, as there are no specific antiviral therapies available for circovirus infections. Prevention strategies include good biosecurity practices, vaccination, and avoidance of contact with infected animals or their feces.

HIV antibodies are proteins produced by the immune system in response to the presence of HIV (Human Immunodeficiency Virus) in the body. These antibodies are designed to recognize and bind to specific parts of the virus, known as antigens, in order to neutralize or eliminate it.

There are several types of HIV antibodies that can be produced, including:

1. Anti-HIV-1 and anti-HIV-2 antibodies: These are antibodies that specifically target the HIV-1 and HIV-2 viruses, respectively.
2. Antibodies to HIV envelope proteins: These antibodies recognize and bind to the outer envelope of the virus, which is covered in glycoprotein spikes that allow the virus to attach to and enter host cells.
3. Antibodies to HIV core proteins: These antibodies recognize and bind to the interior of the viral particle, where the genetic material of the virus is housed.

The presence of HIV antibodies in the blood can be detected through a variety of tests, including enzyme-linked immunosorbent assay (ELISA) and Western blot. A positive test result for HIV antibodies indicates that an individual has been infected with the virus, although it may take several weeks or months after infection for the antibodies to become detectable.

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV) is an enveloped, positive-stranded RNA virus belonging to the Arteriviridae family. It is the causative agent of Porcine Respiratory and Reproductive Syndrome (PRRS), also known as "blue ear disease" or "porcine reproductive and respiratory syndrome."

The virus primarily affects pigs, causing a wide range of clinical signs including respiratory distress in young animals and reproductive failure in pregnant sows. The infection can lead to late-term abortions, stillbirths, premature deliveries, and weak or mummified fetuses. In growing pigs, PRRSV can cause pneumonia, which is often accompanied by secondary bacterial infections.

PRRSV has a tropism for cells of the monocyte-macrophage lineage, and it replicates within these cells, leading to the release of pro-inflammatory cytokines and the development of the clinical signs associated with the disease. The virus is highly infectious and can spread rapidly in susceptible pig populations, making it a significant concern for the swine industry worldwide.

It's important to note that PRRSV has two distinct genotypes: Type 1 (European) and Type 2 (North American). Both types have a high degree of genetic diversity, which can make controlling the virus challenging. Vaccination is available for PRRSV, but it may not provide complete protection against all strains of the virus, and it may not prevent infection or shedding. Therefore, biosecurity measures, such as strict sanitation and animal movement controls, are critical to preventing the spread of this virus in pig populations.

"Macaca nemestrina," also known as the pig-tailed macaque, is not a medical term but a species name in biology. It refers to a specific species of monkey that is native to Southeast Asia. The pig-tailed macaque is a medium-sized monkey with a reddish-brown fur and a distinctive tail that resembles a pig's tail. They are omnivorous and live in social groups that can range from a few individuals to several hundred.

While "Macaca nemestrina" may not have a direct medical definition, these monkeys have been used as models in biomedical research due to their close genetic relationship with humans. Some studies involving pig-tailed macaques have contributed to our understanding of various human diseases and conditions, such as infectious diseases, neurological disorders, and reproductive health. However, it is important to note that the use of animals in research remains a controversial topic, and ethical considerations must be taken into account when conducting such studies.

Attenuated vaccines consist of live microorganisms that have been weakened (attenuated) through various laboratory processes so they do not cause disease in the majority of recipients but still stimulate an immune response. The purpose of attenuation is to reduce the virulence or replication capacity of the pathogen while keeping it alive, allowing it to retain its antigenic properties and induce a strong and protective immune response.

Examples of attenuated vaccines include:

1. Sabin oral poliovirus vaccine (OPV): This vaccine uses live but weakened polioviruses to protect against all three strains of the disease-causing poliovirus. The weakened viruses replicate in the intestine and induce an immune response, which provides both humoral (antibody) and cell-mediated immunity.
2. Measles, mumps, and rubella (MMR) vaccine: This combination vaccine contains live attenuated measles, mumps, and rubella viruses. It is given to protect against these three diseases and prevent their spread in the population.
3. Varicella (chickenpox) vaccine: This vaccine uses a weakened form of the varicella-zoster virus, which causes chickenpox. By introducing this attenuated virus into the body, it stimulates an immune response that protects against future infection with the wild-type virus.
4. Yellow fever vaccine: This live attenuated vaccine is used to prevent yellow fever, a viral disease transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. The vaccine contains a weakened form of the yellow fever virus that cannot cause the disease but still induces an immune response.
5. Bacillus Calmette-Guérin (BCG) vaccine: This live attenuated vaccine is used to protect against tuberculosis (TB). It contains a weakened strain of Mycobacterium bovis, which does not cause TB in humans but stimulates an immune response that provides some protection against the disease.

Attenuated vaccines are generally effective at inducing long-lasting immunity and can provide robust protection against targeted diseases. However, they may pose a risk for individuals with weakened immune systems, as the attenuated viruses or bacteria could potentially cause illness in these individuals. Therefore, it is essential to consider an individual's health status before administering live attenuated vaccines.

Hepatitis C antibodies are proteins produced by the immune system in response to an infection with the hepatitis C virus (HCV). Detection of these antibodies in the blood indicates a past or present HCV infection. However, it does not necessarily mean that the person is currently infected, as antibodies can persist for years even after the virus has been cleared from the body. Additional tests are usually needed to confirm whether the infection is still active and to guide treatment decisions.

A gene product is the biochemical material, such as a protein or RNA, that is produced by the expression of a gene. Env, short for "envelope," refers to a type of gene product that is commonly found in enveloped viruses. The env gene encodes the viral envelope proteins, which are crucial for the virus's ability to attach to and enter host cells during infection. These envelope proteins typically form a coat around the exterior of the virus and interact with receptors on the surface of the host cell, triggering the fusion or endocytosis processes that allow the viral genome to enter the host cell.

Therefore, in medical terms, 'Gene Products, env' specifically refers to the proteins or RNA produced by the env gene in enveloped viruses, which play a critical role in the virus's infectivity and pathogenesis.

An antigen is any substance that can stimulate an immune response, particularly the production of antibodies. Viral antigens are antigens that are found on or produced by viruses. They can be proteins, glycoproteins, or carbohydrates present on the surface or inside the viral particle.

Viral antigens play a crucial role in the immune system's recognition and response to viral infections. When a virus infects a host cell, it may display its antigens on the surface of the infected cell. This allows the immune system to recognize and target the infected cells for destruction, thereby limiting the spread of the virus.

Viral antigens are also important targets for vaccines. Vaccines typically work by introducing a harmless form of a viral antigen to the body, which then stimulates the production of antibodies and memory T-cells that can recognize and respond quickly and effectively to future infections with the actual virus.

It's worth noting that different types of viruses have different antigens, and these antigens can vary between strains of the same virus. This is why there are often different vaccines available for different viral diseases, and why flu vaccines need to be updated every year to account for changes in the circulating influenza virus strains.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

I'm sorry for any confusion, but "Macaca" is not a medical term. It is the name of a genus that includes several species of monkeys, commonly known as macaques. These primates are often used in biomedical research due to their similarities with humans in terms of genetics and physiology. If you have any questions related to medicine or health, I would be happy to try to help answer them.

Yellow fever virus (YFV) is an single-stranded RNA virus belonging to the Flaviviridae family, genus Flavivirus. It is primarily transmitted to humans through the bite of infected mosquitoes, most commonly Aedes and Haemagogus species. The virus is named for the jaundice that can occur in some patients, giving their skin and eyes a yellowish color.

Yellow fever is endemic in tropical regions of Africa and South America, with outbreaks occurring when large numbers of people are infected. After an incubation period of 3 to 6 days, symptoms typically begin with fever, chills, headache, back pain, and muscle aches. In more severe cases, the infection can progress to cause bleeding, organ failure, and death.

Prevention measures include vaccination, mosquito control, and personal protective measures such as wearing long sleeves and using insect repellent in areas where yellow fever is endemic or outbreaks are occurring.

Torque teno virus (TTV) is a single-stranded DNA virus that belongs to the family Anelloviridae. It was first identified in 1997 and has since been found to be present in the majority of human populations worldwide. The virus is classified into several genotypes and subtypes, with TTV being the prototype member of the genus Alphainellovirus.

TTV is a small virus, measuring only about 30-40 nanometers in diameter. It has a circular genome that ranges in size from 2.8 to 3.9 kilobases and encodes for several non-structural proteins involved in viral replication. The virus does not appear to cause any specific disease symptoms, but it has been associated with various clinical conditions such as liver disease, respiratory tract infections, and cancer.

TTV is primarily transmitted through the fecal-oral route, although other modes of transmission have also been suggested, including saliva, blood, and vertical transmission from mother to child during pregnancy or delivery. The virus has been detected in various body fluids, tissues, and organs, including blood, stool, respiratory secretions, and the liver.

The clinical significance of TTV infection remains unclear, as it is frequently found in both healthy individuals and those with various diseases. However, some studies have suggested that TTV viral load or genotype may be associated with certain clinical conditions, such as liver disease, transplant rejection, and cancer. Further research is needed to better understand the role of TTV in human health and disease.

Acquired Immunodeficiency Syndrome (AIDS) is a chronic, life-threatening condition caused by the Human Immunodeficiency Virus (HIV). AIDS is the most advanced stage of HIV infection, characterized by the significant weakening of the immune system, making the person more susceptible to various opportunistic infections and cancers.

The medical definition of AIDS includes specific criteria based on CD4+ T-cell count or the presence of certain opportunistic infections and diseases. According to the Centers for Disease Control and Prevention (CDC), a person with HIV is diagnosed with AIDS when:

1. The CD4+ T-cell count falls below 200 cells per cubic millimeter of blood (mm3) - a normal range is typically between 500 and 1,600 cells/mm3.
2. They develop one or more opportunistic infections or cancers that are indicative of advanced HIV disease, regardless of their CD4+ T-cell count.

Some examples of these opportunistic infections and cancers include:

* Pneumocystis pneumonia (PCP)
* Candidiasis (thrush) affecting the esophagus, trachea, or lungs
* Cryptococcal meningitis
* Toxoplasmosis of the brain
* Cytomegalovirus disease
* Kaposi's sarcoma
* Non-Hodgkin's lymphoma
* Invasive cervical cancer

It is important to note that with appropriate antiretroviral therapy (ART), people living with HIV can maintain their CD4+ T-cell counts, suppress viral replication, and prevent the progression to AIDS. Early diagnosis and consistent treatment are crucial for managing HIV and improving life expectancy and quality of life.

Anti-retroviral agents are a class of drugs used to treat and prevent infections caused by retroviruses, most commonly the human immunodeficiency virus (HIV). These medications work by interfering with the replication process of the retrovirus, thereby preventing it from infecting and destroying immune cells.

There are several different classes of anti-retroviral agents, including:

1. Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) - These drugs block the action of the reverse transcriptase enzyme, which is necessary for the retrovirus to convert its RNA into DNA.
2. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) - These drugs bind directly to the reverse transcriptase enzyme and alter its shape, preventing it from functioning properly.
3. Protease inhibitors (PIs) - These drugs block the action of the protease enzyme, which is necessary for the retrovirus to assemble new viral particles.
4. Integrase inhibitors (INIs) - These drugs block the action of the integrase enzyme, which is necessary for the retrovirus to integrate its DNA into the host cell's genome.
5. Fusion inhibitors - These drugs prevent the retrovirus from entering host cells by blocking the fusion of the viral and host cell membranes.
6. Entry inhibitors - These drugs prevent the retrovirus from attaching to and entering host cells.

Anti-retroviral therapy (ART) typically involves a combination of at least three different anti-retroviral agents from two or more classes, in order to effectively suppress viral replication and prevent drug resistance. Regular monitoring of viral load and CD4+ T cell counts is necessary to ensure the effectiveness of ART and make any necessary adjustments to the treatment regimen.

"Gene products, GAG" refer to the proteins that are produced by the GAG (Group-specific Antigen) gene found in retroviruses, such as HIV (Human Immunodeficiency Virus). These proteins play a crucial role in the structure and function of the viral particle or virion.

The GAG gene encodes for a polyprotein that is cleaved by a protease into several individual proteins, including matrix (MA), capsid (CA), and nucleocapsid (NC) proteins. These proteins are involved in the formation of the viral core, which encloses the viral RNA genome and associated enzymes required for replication.

The MA protein is responsible for binding to the host cell membrane during viral entry, while the CA protein forms the capsid shell that surrounds the viral RNA and NC protein. The NC protein binds to the viral RNA and helps to package it into the virion during assembly. Overall, GAG gene products are essential for the life cycle of retroviruses and are important targets for antiretroviral therapy in HIV-infected individuals.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

I'm sorry for any confusion, but "Viral Hepatitis, Animal" is not a standard medical classification or definition. Hepatitis refers to inflammation of the liver, and viral hepatitis refers to inflammation caused by a virus. The term "animal" in this context doesn't provide a clear meaning.

However, it's worth noting that some animals can contract viral hepatitis, similar to humans. For instance, there are hepatitis A, B, and C-like viruses that have been identified in various animal species. These are typically not transmissible to humans.

If you're referring to a specific medical condition or context, could you please provide more details? I'd be happy to help further with more information.

Alphavirus infections refer to a group of diseases caused by viruses belonging to the Alphavirus genus of the Togaviridae family. These viruses are transmitted to humans through the bite of infected mosquitoes, and can cause a range of symptoms depending on the specific virus and the individual's immune response.

Some of the more common alphaviruses that cause human disease include:

* Chikungunya virus (CHIKV): This virus is transmitted by Aedes mosquitoes and can cause a fever, rash, and severe joint pain. While most people recover from CHIKV infection within a few weeks, some may experience long-term joint pain and inflammation.
* Eastern equine encephalitis virus (EEEV): This virus is transmitted by mosquitoes that feed on both birds and mammals, including humans. EEEV can cause severe neurological symptoms such as fever, headache, seizures, and coma. It has a high mortality rate of up to 30-50% in infected individuals.
* Western equine encephalitis virus (WEEV): This virus is also transmitted by mosquitoes that feed on both birds and mammals. WEEV can cause mild flu-like symptoms or more severe neurological symptoms such as fever, headache, and seizures. It has a lower mortality rate than EEEV but can still cause significant illness.
* Venezuelan equine encephalitis virus (VEEV): This virus is transmitted by mosquitoes that feed on horses and other mammals, including humans. VEEV can cause mild flu-like symptoms or more severe neurological symptoms such as fever, headache, and seizures. It is considered a potential bioterrorism agent due to its ability to cause severe illness and death in large populations.

There are no specific treatments for alphavirus infections other than supportive care to manage symptoms. Prevention measures include avoiding mosquito bites through the use of insect repellent, wearing long sleeves and pants, and staying indoors during peak mosquito hours. Public health efforts also focus on reducing mosquito populations through environmental controls such as eliminating standing water and using insecticides.

West Nile Virus (WNV) vaccines are immunizations that are designed to protect against the West Nile virus, which is a single-stranded RNA virus that belongs to the family Flaviviridae. The virus is primarily transmitted to humans through the bite of infected mosquitoes, particularly those of the Culex species.

There are currently no licensed WNV vaccines available for human use in the United States or Europe. However, there are several veterinary vaccines that have been developed and approved for use in horses and other animals, such as birds and geese. These vaccines work by stimulating the immune system to produce antibodies against the virus, which can help prevent infection and reduce the severity of symptoms in animals that do become infected.

Human WNV vaccine candidates are in various stages of development and testing. Some of these vaccines use inactivated or weakened forms of the virus, while others use only a portion of the viral protein to stimulate an immune response. While these vaccines have shown promise in clinical trials, further research is needed to determine their safety and effectiveness in larger populations before they can be approved for widespread use.

In the context of medicine, plasma refers to the clear, yellowish fluid that is the liquid component of blood. It's composed of water, enzymes, hormones, antibodies, clotting factors, and other proteins. Plasma serves as a transport medium for cells, nutrients, waste products, gases, and other substances throughout the body. Additionally, it plays a crucial role in the immune response and helps regulate various bodily functions.

Plasma can be collected from blood donors and processed into various therapeutic products, such as clotting factors for people with hemophilia or immunoglobulins for patients with immune deficiencies. This process is called plasma fractionation.

HIV Long-Term Survivors are individuals who have been living with HIV for an extended period, typically defined as 10 years or more after the initial diagnosis. Despite the challenges and health complications associated with HIV infection and treatment, these survivors have successfully navigated the complexities of managing their condition and maintaining their health over the long term.

It is important to note that HIV Long-Term Survivors face unique medical and psychosocial challenges, including an increased risk of age-related comorbidities, cognitive decline, and mental health issues such as depression and anxiety. As a result, ongoing medical care and support are essential for maintaining their overall health and wellbeing.

While the definition of HIV Long-Term Survivors may vary depending on the source, it is generally accepted that these individuals have demonstrated remarkable resilience and adaptability in living with HIV over an extended period. Their experiences provide valuable insights into the long-term effects of HIV infection and treatment, as well as the importance of providing comprehensive care and support to those living with this chronic condition.

Circoviruses are a type of small, non-enveloped viruses that belong to the family Circoviridae. They have a single-stranded, circular DNA genome and can infect a wide range of hosts, including birds, pigs, and some mammals. Circoviruses are associated with various diseases in animals, such as porcine circovirus-associated disease (PCVAD) in pigs and beak and feather disease in birds. However, there is currently no evidence to suggest that circoviruses infect or cause disease in humans.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Drug resistance, viral, refers to the ability of a virus to continue replicating in the presence of antiviral drugs that are designed to inhibit or stop its growth. This occurs when the virus mutates and changes its genetic makeup in such a way that the drug can no longer effectively bind to and inhibit the function of its target protein, allowing the virus to continue infecting host cells and causing disease.

Viral drug resistance can develop due to several factors, including:

1. Mutations in the viral genome that alter the structure or function of the drug's target protein.
2. Changes in the expression levels or location of the drug's target protein within the virus-infected cell.
3. Activation of alternative pathways that allow the virus to replicate despite the presence of the drug.
4. Increased efflux of the drug from the virus-infected cell, reducing its intracellular concentration and effectiveness.

Viral drug resistance is a significant concern in the treatment of viral infections such as HIV, hepatitis B and C, herpes simplex virus, and influenza. It can lead to reduced treatment efficacy, increased risk of treatment failure, and the need for more toxic or expensive drugs. Therefore, it is essential to monitor viral drug resistance during treatment and adjust therapy accordingly to ensure optimal outcomes.

Hepatitis antibodies are proteins produced by the immune system in response to an infection caused by a hepatitis virus. There are several types of hepatitis viruses, including A, B, C, D, and E, each with their own specific antibodies.

The presence of hepatitis antibodies in the blood can indicate a current or past infection with the corresponding hepatitis virus. For example, the detection of anti-HAV (hepatitis A virus) antibodies indicates a past infection or immunization against hepatitis A, while the detection of anti-HBs (hepatitis B surface antigen) antibodies indicates immunity due to vaccination or recovery from a hepatitis B infection.

It's important to note that some hepatitis antibodies may not provide immunity to future infections, and individuals can still be infected with the virus even if they have previously produced antibodies against it. Therefore, regular testing and vaccination are essential for preventing the spread of hepatitis viruses and protecting public health.

Flaviviridae is a family of viruses that includes many important human pathogens. According to the International Committee on Taxonomy of Viruses (ICTV), Flaviviridae is divided into four genera: Flavivirus, Hepacivirus, Pegivirus, and Pestivirus. These viruses are enveloped and have a single-stranded, positive-sense RNA genome.

1. Flavivirus genus includes several medically important viruses, such as dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, Zika virus, and tick-borne encephalitis virus. These viruses are primarily transmitted by arthropod vectors (mosquitoes or ticks) and can cause a wide range of symptoms, from mild febrile illness to severe hemorrhagic fever and neuroinvasive disease.
2. Hepacivirus genus contains hepatitis C virus (HCV), which is a major causative agent of viral hepatitis and liver diseases, such as cirrhosis and hepatocellular carcinoma. HCV is primarily transmitted through percutaneous exposure to infected blood or blood products, sexual contact, and mother-to-child transmission during childbirth.
3. Pegivirus genus includes pegiviruses (formerly known as GB viruses) that are associated with persistent infection in humans and other animals. While pegiviruses can cause acute illness, they are mostly linked to asymptomatic or mild infections.
4. Pestivirus genus contains several animal pathogens, such as bovine viral diarrhea virus (BVDV), Classical swine fever virus (CSFV), and border disease virus (BDV). These viruses can cause significant economic losses in the livestock industry due to reproductive failure, growth retardation, and immunosuppression.

In summary, Flaviviridae is a family of enveloped, single-stranded, positive-sense RNA viruses that includes several important human and animal pathogens. The family is divided into four genera: Flavivirus, Hepacivirus, Pegivirus, and Pestivirus.

Dengue vaccines are designed to protect against dengue fever, a mosquito-borne viral disease that can cause severe flu-like symptoms and potentially life-threatening complications. Dengue is caused by four distinct serotypes of the virus (DENV-1, DENV-2, DENV-3, and DENV-4), and infection with one serotype does not provide immunity against the others.

The first licensed dengue vaccine, Dengvaxia (CYD-TDV), is a chimeric yellow fever-dengue tetravalent vaccine developed by Sanofi Pasteur. It is approved for use in several countries and has demonstrated efficacy against dengue fever caused by all four serotypes in clinical trials. However, the vaccine has raised concerns about the risk of severe disease in individuals who have not been previously exposed to dengue. As a result, it is recommended primarily for people with a documented past dengue infection or living in areas with high dengue prevalence and where the benefits outweigh the risks.

Another dengue vaccine candidate, Takeda's TAK-003 (also known as TDV), is a live attenuated tetravalent dengue vaccine that has shown efficacy against all four serotypes in clinical trials. It was granted approval by the European Medicines Agency (EMA) and several other countries for use in individuals aged 4-16 years old, living in endemic areas.

Research and development of additional dengue vaccine candidates are ongoing to address concerns about safety, efficacy, and accessibility, particularly for at-risk populations in low- and middle-income countries where dengue is most prevalent.

The Yellow Fever Vaccine is a vaccine that protects against the yellow fever virus, which is transmitted to humans through the bites of infected mosquitoes. The vaccine contains live, weakened yellow fever virus, and it works by stimulating the immune system to produce an immune response that provides protection against the disease.

The yellow fever vaccine is recommended for people who are traveling to areas where yellow fever is common, including parts of Africa and South America. It is also required for entry into some countries in these regions. The vaccine is generally safe and effective, but it can cause mild side effects such as headache, muscle pain, and fever in some people. Serious side effects are rare, but may include allergic reactions or infection with the weakened virus used in the vaccine.

It's important to note that yellow fever vaccine may not be recommended for certain individuals, including infants younger than 6 months, pregnant women, people with weakened immune systems, and those with a history of severe allergic reaction to a previous dose of the vaccine or any component of the vaccine. It is always best to consult with a healthcare provider before receiving any vaccination.

Mononuclear leukocytes are a type of white blood cells (leukocytes) that have a single, large nucleus. They include lymphocytes (B-cells, T-cells, and natural killer cells), monocytes, and dendritic cells. These cells play important roles in the body's immune system, including defending against infection and disease, and participating in immune responses and surveillance. Mononuclear leukocytes can be found in the bloodstream as well as in tissues throughout the body. They are involved in both innate and adaptive immunity, providing specific and nonspecific defense mechanisms to protect the body from harmful pathogens and other threats.

Secondary viremia occurs when primary viremia has resulted in infection of additional tissues via bloodstream, in which the ... Viremia is a medical condition where viruses enter the bloodstream and hence have access to the rest of the body. It is similar ... Primary viremia refers to the initial spread of virus in the blood from the first site of infection.[medical citation needed] ... Passive viremia is the introduction of viruses in the bloodstream without the need of active viral replication. Examples ...
... is the fifth studio album by Finnish industrial experimental black metal band, Havoc Unit ( ...
... virus has been shown to infect a wide variety of fish species including silver carp, grass carp, ... Spring viraemia of carp, also known as swim bladder inflammation, is caused by Carp sprivivirus, also called Rhabdovirus carpio ... Spring Viraemia of Carp expert reviewed and published by Wikivet, accessed 08/10/2011. (Articles with short description, Short ... 2002). "Spring viremia of carp (SVC)". Diseases of Aquatic Organisms. 52 (3): 261-272. doi:10.3354/dao052261. PMID 12553453. ...
Viral Infection is viremia. Malaria and trypanosomiasis are blood-borne parasitic infections. Substances other than oxygen can ...
In 95% of cases only a primary, transient presence of viremia (virus in the bloodstream) occurs, and the poliovirus infection ... All theories require primary viremia. The first hypothesis predicts that virions pass directly from the blood into the central ... The sustained viral replication causes secondary viremia and leads to the development of minor symptoms such as fever, headache ...
In bone marrow transplant recipients it is notable as a cause for hemorrhagic cystitis.[citation needed] BK viremia load > 185 ...
Manuelidis, Elias E.; Gorgacs, Edward J.; Manuelidis, Laura (1978-06-02). "Viremia in Experimental Creutzfeldt-Jakob Disease". ...
In 2002, spring viraemia struck an ornamental koi farm in Kernersville, North Carolina, and required complete depopulation of ... mitchkoi.co.uk Spring Viremia of Carp. Impact Worksheet•17 July 2002 "Blackwater Creek Koi Farms" Archived 21 March 2015 at the ... which causes spring viraemia of carp (SVC). No treatment is known for either disease. Some koi farms in Israel use the KV3 ...
De Harven, E; Friend, C (1966). "Origin of the viremia in murine leukemia". National Cancer Institute Monograph. 22: 79-105. ...
2006). "Vesivirus viremia and seroprevalence in humans". J. Med. Virol. 30 (8): 693-701. doi:10.1002/jmv.20594. PMC 7166889. ...
They develop tremendous viremia and infect the ticks. The vector for disease transmission is Haemaphysalis spinigera, a forest ... Upadhyaya, S.; Narasimha Murthy, D. P.; Yashodhara Murthy, B. K. (July 1975). "Viraemia studies on the Kyasanur Forest Disease ...
... abrogates viremia in Zika virus-infected rhesus Macaques. Galidesivir is one of several antiviral drugs being ... June 2020). "A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques". Science Translational ...
Subsequent replication occurs in other organs, leading to viremia. Symptoms in horses occur 1-3 weeks after infection, and ...
Laboratory criteria include a decreased lymphocyte count consistent with viremia. However a definitive laboratory diagnosis can ...
The viremia arises because LDV lyses the cell after replication. The virus is most commonly found in the liver, spleen, lymph ... LDV specifically causes lifelong persistent viremia in mice, but does not harm the host and only slightly harms the immune ... Because the virus causes persistent viremia, virus in the bloodstream, it can be spread by blood-sucking ectoparasites. This is ...
The virus isolation in cell culture is effective during viremia. RT-PCR helps to identify virus. Serology tests detect ...
Viremia was recorded seven days after the onset of fever; this is a longer period of viremia than what is normally observed in ... With viraemia lasting 1 to 3 days, they are easily able to spread the virus to vectors including Culicoides midges and Aedes, ... There is a quick period of viraemia before seroconversion and the infection is cleared quickly by the animal's immune system. ...
Viremia (the presence of the virus in the blood) is rare. The virus is shed in saliva and eye and nasal secretions, and can ...
"Human Polyomavirus 7-Associated Pruritic Rash and Viremia in Transplant Recipients". Journal of Infectious Diseases. 211 (10): ...
"Chronic Fatigue Syndrome after Human Parvovirus B19 Infection without Persistent Viremia". Dermatology. 216 (4): 341-6. doi: ...
"Human Polyomavirus 7-Associated Pruritic Rash and Viremia in Transplant Recipients". Journal of Infectious Diseases. 211 (10): ...
"Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients". The Journal of Infectious Diseases. 211 ( ...
Wong, J. K. (1997). "Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia". Science. 278 (5341 ...
Driggers, Rita W. (30 March 2016). "Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities". New ... "Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities," which documents the destruction of a fetal ...
"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia" (PDF). Science. 278 (5341): 1291-95. doi ...
Experimental infections of cattle produced viremia, but no observable signs of illness. BHV, BAV, SWBV and TIBV were isolated ...
"Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant". The New England Journal of Medicine. 369 (19): ...
Groocock GH (2007). "Viral Hemorrhagic Septicemia and Spring Viremia of Carp: Threats to Aquaculture" (PDF). Cornell University ...
The antibody reaction plays an important role in decreasing levels of viremia. Bunyavirus morphology is somewhat similar to ...
Antibiotic prophylaxis Dental antibiotic prophylaxis Fungemia Viremia Viscoli, C (2 April 2016). "Bloodstream Infections: The ...
Secondary viremia occurs when primary viremia has resulted in infection of additional tissues via bloodstream, in which the ... Viremia is a medical condition where viruses enter the bloodstream and hence have access to the rest of the body. It is similar ... Primary viremia refers to the initial spread of virus in the blood from the first site of infection.[medical citation needed] ... Passive viremia is the introduction of viruses in the bloodstream without the need of active viral replication. Examples ...
Viremia occurs when a virus infects the bloodstream. In this article, learn about the types of viruses, symptoms, causes, and ... Primary viremia: This is when the virus enters the bloodstream.. *Secondary viremia: This is when viremia has caused an ... Sometimes the name of the related viral infection is listed to further describe cases of viremia, such as HIV-viremia or West ... Many cases of viremia are mild or harmless, but if the infection becomes severe or affects the vital organs, it may lead to ...
Is low-level viremia associated with a higher rate of viral rebound? ... low-level viremia) is uncertain. To address this issue, investigators assessed whether low-level viremia, measured with an ... Low-level viremia predicts viral rebound, but the absolute risk is low and the next clinical step is unclear. ...
Persistent low-level HIV-1 viremia (pLLV) can occur in people with HIV despite high adherence to antiretroviral therapy (ART), ... These results demonstrate that non-suppressible HIV viremia is driven by the critical intersection of factors at the viral ... Those intact proviruses contributing to plasma viremia were defined as "producers", and those that did not contribute to ... This study represents the most comprehensive assessment of persistent low-level viremia to date and provide insight into ART- ...
In addition, HCV viremia was an independent predictor for negative maternal outcomes including anemia during pregnancy, medical ... Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China. World J Gastroenterol 2022; 28(34): 5023- ... These findings increase the need for close antenatal surveillance in HCV mothers with viremia for maternal complications and ... The study demonstrates a previously unreported association between maternal HCV viremia and a smaller neonate head ...
CMV viraemia precedes disease so the detection of CMV viraemia identifies individuals at highest risk. Cell culture based ...
Spring viremia of carp and other viral diseases and agents of warm-water fish. In Woo, P.T.K. and D.W. Bruno, (eds.) Fish ... Detection of carp antibodies to spring viremia of carp virus by a competitive immuno assay. Diseases of Aquatic Organisms 19: ... Spring Viremia of Carp Virus (SVCV) is a rhabdovirus that under natural conditions infects five species of carp (common-- ... Comparative pathogenicity of two strains of pike fry rhabdovirus and spring viremia of carp virus for young roach, common carp ...
Optimal management of patients experiencing persistent low-level viremia (LLV) remains challenging and poorly understood. This ... Low-level HIV viremia is associated with low antiretroviral prescription refill rates and social deprivation.. Aug 17, 2020 ... Optimal management of patients experiencing persistent low-level viremia (LLV) remains challenging and poorly understood. This ...
HIV-1 DNA drug resistance testing to guide successful suppression of low-level viraemia: a case report ... HIV-1 DNA drug resistance testing to guide successful suppression of low-level viraemia: a case report ...
OBJECTIVE: Low-level viraemia (LLV) occurs in some people with HIV (PWH) receiving antiretroviral therapy (ART) and has been ... OBJECTIVE: Low-level viraemia (LLV) occurs in some people with HIV (PWH) receiving antiretroviral therapy (ART) and has been ... Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy : A Swedish observational study. ... article{83046b27-0414-48b5-a039-bc020ced822a, abstract = {{,p,OBJECTIVE: Low-level viraemia (LLV) occurs in some people with ...
or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. ...
... experienced viraemia. Of the 494 patients who had any ART visits ,2 months after viraemia, 345 (70%) returned to clinic care. ... We identified patients with viraemia (VL,1000 copies/mL) that occurred after joining the club, before they first exited the ... PATIENTS EXPERIENCING VIRAEMIA IN ADHERENCE CLUBS: IS BACK-TO-CLINIC ALWAYS BEST?. ... We describe the implementation of guidelines and 12-month outcomes of club patients who experience viraemia. ...
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co infected with HIV?. Posted at 00:00h in by ...
Our data suggest that reducing maternal viremia during the antenatal period may help to reduce cord blood viremia. � 2019. ... Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia. ... Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia. Pediatrics and Neonatology 60 ( ... ve mothers were younger with higher HBV and cord viremia. At 9 months of age, one infant was infected. Infants delivered by ...
Overall, 44/124 (35.5%) had viraemia, which was associated with undetectable TFV in those receiving efavirenz (OR 6.01, 1.27- ... Undetectable point-of-care urine TFV results were associated with viraemia, particularly among people receiving dolutegravir. ... viraemia ≥1000 copies/ml and HIV drug resistance, among people receiving either efavirenz or dolutegravir-based ART. RESULTS: ... 39.0, p = 0.014) and dolutegravir (OR 25.7, 4.20-294.8, p,0.001). However, in those with viraemia while receiving efavirenz, 8/ ...
The main objective of the study was to determine proportion of Hepatitis B viremia in ART-naïve and ART-experienced co-infected ... Factors associated with viremia were determined using univariate and multivariate logistic regression analysis. Of 3108 HIV- ... Majority of ART-naïve (89 %) and 42 % of ART-experienced patients had detectable hepatitis B viremia > 20 IU/ ... Baseline and on-treatment ALT may be a useful non-invasive predictor of Hepatitis B viremia in resource-constrained countries ...
Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes. J ... "Viremia" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject Headings) ... This graph shows the total number of publications written about "Viremia" by people in this website by year, and whether " ... Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts ...
These kinetics of plasma viremia following ATI were then re-visualized as follows: c The delay in rebound of plasma viremia was ... 4: Cytokine therapy delays the rebound of plasma viremia following ATI.. Following ART analytical treatment interruption (ATI ... Determination of plasma viremia. Six-replicate reaction hybrid qRT-PCR assay was performed to determine SIV-RNA copies per mL ... 4e). Cytokine therapy did not however impact the peak or set-point viremia relative to controls (Supplementary Fig. 10a, b) or ...
Determinação da viremia e da soroprevalência do vírus da Hepatite E (HEV) em doadores de sangue ... Determination of Viremia and Seroprevalence of Hepatitis E vírus (HEV) in blood donors ...
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly ... Primary cytomegalovirus infection and viremia. Both replication of CMV DNA and morphogenesis of the virion capsid take place in ... Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9. 305(2):57-63. [QxMD ... of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, ...
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly ... Primary cytomegalovirus infection and viremia. Both replication of CMV DNA and morphogenesis of the virion capsid take place in ... Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981 Jul 9. 305(2):57-63. [QxMD ... of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, ...
Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subse ... Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subsets. ... Identifying recipients who may experience CMV viremia after liver or intestine transplantation can potentially enhance decision ...
Viral and host mediators of non-suppressible HIV-1 viremia Understanding the heterogeneity of HIV infection, such as in persons ... with non-suppressible HIV-1 viremia despite adherence to antiretroviral treatment, is crucial to better tailor therapeutic ...
Affected individuals are susceptible to infection with EBV and develop EBV viremia and EBV-associated lymphoproliferative ... More variable features may include autoimmune oligoarthritis, interstitial pneumonitis, and EBV viremia. Laboratory studies ... is an autosomal recessive immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia, ...
Therefore, the immunity induced by EDRD1 and its genetically close field isolates may play a role in reducing viremia caused by ... Viremia contributed to the distribution of the virus throughout every organ tested in the infected animals. The virus in Group ... 4a). Virus shedding at 7, 10, and 13 dpi was correlated with viremia (Fig. 4b); high quantities of viral RNA were detected in ... Therefore, the immunity induced by EDRD1 and its genetically close field isolates may play a role in reducing viremia caused by ...
Viremia: Listen [MP3]. The presence of a virus in the blood.. Virulence: Listen [MP3]. The relative capacity of a pathogen to ...
These data suggest that maintenance of moderate viremia may confer clinical benefit not seen when viremia exceeds 20,000 copies ... These data suggest that maintenance of moderate viremia may confer clinical benefit not seen when viremia exceeds 20,000 copies ... These data suggest that maintenance of moderate viremia may confer clinical benefit not seen when viremia exceeds 20,000 copies ... These data suggest that maintenance of moderate viremia may confer clinical benefit not seen when viremia exceeds 20,000 copies ...
Section VIII - Susceptibility to Experimental Infection (include viremia). Experimental host and age Passage history and strain ...
  • Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes. (ouhsc.edu)
  • Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subsets. (plexision.com)
  • Spring Viremia of Carp Virus (SVCV) is a rhabdovirus that under natural conditions infects five species of carp (common--including koi, bighead, grass, silver and crucian), 4 goldfish, 9 and sheatfish. (vin.com)
  • Spring viremia of carp (SVC) is an important disease affecting cyprinids, mainly common carp Cyprinus carpio. (musiceye11.com)
  • Designated a notifiable disease by the Office International des Epizooties, SVC is caused by a rhabdovirus, spring viremia of carp virus (SVCV). (musiceye11.com)
  • In vitro replication of SVCV takes place in the cytoplasm of cultured cells of fish, bird and mammalian origin at temperatures of 4 to 31 degrees C, with an optimum of about 20 degrees C. Spring viremia of carp can be diagnosed by clinical signs, isolation of virus in cell culture and molecular methods. (musiceye11.com)
  • Primary viremia refers to the initial spread of virus in the blood from the first site of infection. (wikipedia.org)
  • medical citation needed] Secondary viremia occurs when primary viremia has resulted in infection of additional tissues via bloodstream, in which the virus has replicated and once more entered the circulation. (wikipedia.org)
  • Viral replication then leads to viremia and the virus spreads to its secondary site of infection, the central nervous system (CNS). (wikipedia.org)
  • Upon infection of the CNS, secondary viremia results and symptoms usually begin. (wikipedia.org)
  • Many cases of viremia are mild or harmless, but if the infection becomes severe or affects the vital organs, it may lead to organ failure or sepsis. (medicalnewstoday.com)
  • The symptoms of viremia often depend on the cause of the infection, but many viral infections cause a similar set of symptoms. (medicalnewstoday.com)
  • This is when viremia has caused an infection in another organ or tissue by spreading through the bloodstream. (medicalnewstoday.com)
  • Sometimes the name of the related viral infection is listed to further describe cases of viremia, such as HIV-viremia or West Nile-viremia. (medicalnewstoday.com)
  • Baseline and on-treatment ALT may be a useful non-invasive predictor of Hepatitis B viremia in resource-constrained countries in sub-Saharan Africa where infection is endemic and viral load tests are not widely available. (biomedcentral.com)
  • Objective: Although highly active antiretroviral therapy has been shown to lower plasma HIV-1 RNA in HIV infection, many patients do not reach the target goal of undetectable viremia. (northwestern.edu)
  • The consistent relationship between Gag-specific immune responses and viremia control suggests that T cell responses are vital in determining the superior outcome of HIV-2 infection. (ox.ac.uk)
  • was also a source of persistent viremia on ART, begging the question of how the AMBI-1 clone can survive despite infection with a replication-competent, actively-expressing provirus. (frontiersin.org)
  • Here we have examined two of the new antibodies, directed to the CD4-binding site and the V3 region (3BNC117 and 10-1074, respectively), for their ability to block infection and suppress viraemia in macaques infected with the R5 tropic simian-human immunodeficiency virus (SHIV)-AD8, which emulates many of the pathogenic and immunogenic properties of HIV-1 during infections of rhesus macaques. (pasteur.fr)
  • In a pregnant woman, placental infection occurs during viremia and may lead to transplacental fetal infection. (cdc.gov)
  • Our data suggest that reducing maternal viremia during the antenatal period may help to reduce cord blood viremia. (nus.edu.sg)
  • Furthermore, patients with undetectable viremia had greater Gag-specific responses compared with patients with high viral replication. (ox.ac.uk)
  • Population viremia -- % of all adults (HIV+ or HIV-) with HIV viremia - was estimated at midpoint of follow-up based on HIV prevalence and non-suppression among HIV+, with adjustment for differences between the measurement cohort and underlying population. (larmarange.net)
  • 028), whereas use of an ACEi/ARB had no effect on prevalence of viremia. (techblessing.com)
  • Thus, also HIV-2-infected without viremia may be eligible for antiretroviral treatment. (lu.se)
  • Low-level viremia predicts viral rebound, but the absolute risk is low and the next clinical step is unclear. (medscape.com)
  • To address this issue, investigators assessed whether low-level viremia, measured with an assay that has a detection limit of 3 copies/mL, is a predictor of viral rebound. (medscape.com)
  • However, higher fractions and levels of RNA were found in cells with proviruses containing multiple drug resistance mutations, including those contributing to rebound viremia. (frontiersin.org)
  • By this model, persistent and rebound viremia originates from the occasional activation of a small fraction of the pool of latently-infected cells. (frontiersin.org)
  • In multivariate analysis of all patients, being ART-naïve (OR 10.1, 95 % CI 4.6 - 21.9) and elevated ALT (OR 3.7, 95 % CI 1.8 - 7.9) were associated with Hepatitis B viremia. (biomedcentral.com)
  • In treatment experienced patients, elevated ALT (OR 4.8 CI 2.0 - 12.1) and male sex (OR 2.1, 95 % CI 1.0 - 4.2) were associated with Hepatitis B viremia. (biomedcentral.com)
  • An abnormal serum ALT was significantly associated with hepatitis B viremia in HBV and HIV co-infected patients irrespective of treatment status. (biomedcentral.com)
  • Does hepatitis C viremia or genotype predict the risk of mortality in individuals co infected with HIV? (aighd.org)
  • Conclusion: HLA genotype influences the host capacity to clear HCV viremia. (johnshopkins.edu)
  • Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. (bvsalud.org)
  • Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. (ox.ac.uk)
  • In this study, using a large cohort of 1,759 patients infected with HCV genotype 3, we explore the role of genetic variants on the response to interferon (IFN) and direct-acting antiviral (DAA) regimens and viremia in a combined candidate gene and genome-wide analysis. (ox.ac.uk)
  • Our results provide evidence for a role of genetic variants on HCV viremia and SVR, notably DAA-based, in patients infected with HCV genotype 3. (ox.ac.uk)
  • Viremia is a medical condition where viruses enter the bloodstream and hence have access to the rest of the body. (wikipedia.org)
  • Viremia is the medical term for when viruses enter the bloodstream. (medicalnewstoday.com)
  • Some viruses can enter the bloodstream, leading to viremia. (medicalnewstoday.com)
  • CMV viraemia precedes disease so the detection of CMV viraemia identifies individuals at highest risk. (bmj.com)
  • This study compared HCV RNA with HCVcAg for the detection and quantification of viraemia among a sample of Egyptians. (who.int)
  • Optimal management of patients experiencing persistent low-level viremia (LLV) remains challenging and poorly understood. (physiciansweekly.com)
  • We describe the implementation of guidelines and 12-month outcomes of club patients who experience viraemia. (croiconference.org)
  • Of 8680 total club patients with a median time of 29.8 months in clubs (IQR:20-51) and VL testing data available, 503 (6%) experienced viraemia. (croiconference.org)
  • The main objective of the study was to determine proportion of Hepatitis B viremia in ART-naïve and ART-experienced co-infected Ghanaian patients and factors associated with HBV viremia after at least 36 weeks of lamivudine with or without tenofovir containing ART. (biomedcentral.com)
  • Patients with intermittent viremia had a median of 27% of their values with less than 2.5 copies/mL compared with a median of 56% for patients with complete viral suppression ( P = .04, Wilcoxon rank-sum test). (jamanetwork.com)
  • Patients were classified at time 0 (the end of the ACTG 343 induction phase [following 24 weeks of therapy] when patients were eligible to exhibit virologic failure) according to whether they met the definition of intermittent viremia (at any time point during the study) or suppressed viremia. (jamanetwork.com)
  • Studies of human leukocyte antigen (HLA) alleles and their relation with hepatitis C virus (HCV) viremia have had conflicting results. (johnshopkins.edu)
  • OBJECTIVE: Low-level viraemia (LLV) occurs in some people with HIV (PWH) receiving antiretroviral therapy (ART) and has been linked to inferior treatment outcomes. (lu.se)
  • Following the example of the previous use of metagenomic libraries to detect human pathogens ( 7 - 9 ), we developed a bioinformatics-based method to screen existing libraries for HHpgV-1 and HPgV sequences from previously tested persons in the United Kingdom, enabling viremia frequencies in different risk groups to be estimated. (blogspot.com)
  • Vaccination must be done before secondary viremia takes place for the individual to avoid brain damage or death. (wikipedia.org)
  • Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes. (ouhsc.edu)
  • In some cases, a doctor may diagnose viremia by comparing a person's symptoms with those of other viral infections that someone has potentially been exposed to. (medicalnewstoday.com)
  • Lymphoproliferative syndrome-2, also known as CD27 deficiency, is an autosomal recessive immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia, and impairment in specific antibody function resulting from impaired T cell-dependent B-cell responses and T-cell dysfunction (summary by van Montfrans et al. (nih.gov)
  • Reduced posttransplant viremia was directly correlated with antibody titers against gB consistent with a humoral response against gB being important. (londonmet.ac.uk)
  • Examples include the measles, in which primary viremia occurs in the epithelial lining of the respiratory tract before replicating and budding out of the cell basal layer (viral shedding), resulting in viruses budding into capillaries and blood vessels. (wikipedia.org)
  • medical citation needed] Usually secondary viremia results in higher viral shedding and viral loads within the bloodstream due to the possibility that the virus is able to reach its natural host cell from the bloodstream and replicate more efficiently than the initial site. (wikipedia.org)
  • This randomised clinical trial will assess if the availability of resistance testing improves clinical outcomes in children and adolescents with elevated viremia while taking ART . (bvsalud.org)
  • These data suggest that maintenance of moderate viremia may confer clinical benefit not seen when viremia exceeds 20,000 copies/mL, and this should be taken into account when considering the risks and benefits of continuing failing therapy. (northwestern.edu)
  • HBeAg +ve mothers were younger with higher HBV and cord viremia. (nus.edu.sg)
  • Infants delivered by HBeAg positive mothers and mothers with high HBV DNA of more than 6 LOG IU/mL (1 x 106 IU/mL) have increased relative risk of cord blood viremia. (nus.edu.sg)
  • The risk can be considerable due to their short periods of asymptomatic viremia in the population with variable and sometimes extremely high incidence. (bvsalud.org)
  • Factors associated with viremia were determined using univariate and multivariate logistic regression analysis. (biomedcentral.com)
  • Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study / Lombardi, F. (unisr.it)
  • Our primary analyses evaluated associations between 12 HLA alleles identified through a critical review of the literature and HCV viremia in 758 HCV-seropositive women. (johnshopkins.edu)
  • Lower population-level HIV viremia was associated with lower HIV incidence in all four Universal Test and Treat Studies, conducted in a wide range of epidemic contexts in sub-Saharan Africa. (larmarange.net)
  • http://www.croiconference.org/sessions/population-level-viremia-predicts-hiv-incidence-across-universal-test-treat-studies. (larmarange.net)
  • Le risque peut être considérable en raison de leurs courtes périodes de virémie asymptomatique dans la population dont l'incidence est variable et parfois extrêmement élevée. (bvsalud.org)
  • Identifying recipients who may experience CMV viremia after liver or intestine transplantation can potentially enhance decision making about the need for, and the timing and length of prophylactic antiviral therapy. (plexision.com)
  • The magnitude of the IFN-γ immune response to the HIV-2 proteome was inversely correlated with HIV-2 viremia, and this relationship was specifically due to the targeting of Gag. (ox.ac.uk)
  • We aimed to determine the correlation between maternal serum and umbilical cord blood HBV DNA levels in infants delivered by chronic HBV-infected mothers and to describe the effect of cord blood viremia on vertical transmission. (nus.edu.sg)
  • Participants are randomised in a 11 allocation to a control arm receiving the standard of care (3 sessions of enhanced adherence counselling, a follow-up VL test, continuation of the same regimen upon viral resuppression or empiric selection of a new regimen upon sustained elevated viremia ) and an intervention arm (GRT to inform onward treatment ). (bvsalud.org)
  • Is cytomegalovirus viraemia a useful tool in managing CMV disease? (bmj.com)
  • High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy. (ox.ac.uk)
  • the subject with a missing measurement was in the group without intermittent viremia. (jamanetwork.com)
  • All except 1 in the low-dose group developed detectable viremia. (nih.gov)
  • Viremia is classified into types depending on how the virus infected the bloodstream. (medicalnewstoday.com)
  • RÉSUMÉ L'infection par le virus de l'hépatite C (VHC) est répandue en Égypte. (who.int)
  • Les examens ont été réalisés au Centre d'Infectiologie Charles Mérieux (CICM) de Bamako avec le dépistage du génome des virus responsables de la Dengue, de la fièvre de la Vallée du Rift, et du Zika à l'aide de la technique de la RT-PCR en temps réel. (bvsalud.org)
  • This study represents the most comprehensive assessment of persistent low-level viremia to date and provide insight into ART-independent factors necessary for HIV clearance. (natap.org)
  • Community-level regression, adjusted for study, was used to quantify the association between HIV incidence and viremia and to evaluate cross-study heterogeneity. (larmarange.net)
  • Minor cases of viremia can be relatively harmless and resolve on their own. (medicalnewstoday.com)
  • This graph shows the total number of publications written about "Viremia" by people in this website by year, and whether "Viremia" was a major or minor topic of these publications. (ouhsc.edu)
  • Blood tests and blood cultures may also be necessary to determine or confirm the specific cause of viral infections and viremia. (medicalnewstoday.com)
  • citation needed] Active viremia is caused by the replication of viruses which results in viruses being introduced into the bloodstream. (wikipedia.org)
  • These results demonstrate that non-suppressible HIV viremia is driven by the critical intersection of factors at the viral genetic, epigenetic and cellular level (Figure). (natap.org)
  • GC Env-specific memory B cell responses elicited early post-systemic boosting correlated significantly with decreased viremia postinfection. (edu.pe)
  • Persistent low-level HIV-1 viremia (pLLV) can occur in people with HIV despite high adherence to antiretroviral therapy (ART), without significant drug resistance, and due to unclear mechanisms. (natap.org)
  • Below are the most recent publications written about "Viremia" by people in Profiles. (ouhsc.edu)
  • Despite effective antiretroviral therapies (ARTs), a subset of people living with HIV (PLWH) still experience low-level viremia (LLV, i.e., 50-1,000 copies/mL). (unisr.it)
  • Using data from four large Universal Test and Treat Trials, we evaluated the relationship between viremia and incidence and its consistency across epidemic contexts. (larmarange.net)
  • however, both strength of the incidence-viremia relationship (slope) and projected incidence at 0% viremia (intercept) differed (Figure). (larmarange.net)
  • When administered together, a single treatment rapidly suppressed plasma viraemia for 3-5 weeks in some long-term chronically SHIV-infected animals with low CD4(+) T-cell levels. (pasteur.fr)
  • The association of GBV-C viremia with reduced mortality remained significant in analyses stratified according to age and CD4+ cell count. (nih.gov)
  • For all subjects the mean incubation period was 5.9 days (range 5-9 days) and mean time of viremia was 6.8 days (range 3-9 days). (nih.gov)